Browsing Tag
Femasys Inc.
3 posts
Why Femasys’ FDA-cleared next-generation FemVue device could reshape non-radiation fertility diagnostics in the U.S.
Find out how Femasys’ FDA-cleared next-generation FemVue device could reshape non-radiation fertility diagnostics and influence the U.S. women’s health market today.
PharmaCyte Biotech turns Femasys investment into cash windfall, fueling new strategic opportunities
Find out how PharmaCyte Biotech’s monetized Femasys stake strengthens liquidity and fuels new strategic opportunities.
FDA approval and $12m funding propel Femasys’ FemBloc toward market-ready milestone
Discover how Femasys’ FemBloc advances with FDA clearance and $12 M in funding, propelling its non-surgical birth control toward commercialization.